Homology Medicines, Inc. (0T6G.L)
USD 3.22
(-5.26%)
USD 3.22
(-5.26%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -7.41 USD | -371.97% |
| 2022 | -1.57 USD | 94.96% |
| 2021 | -31.18 USD | 38.21% |
| 2020 | -50.46 USD | -13.62% |
| 2019 | -44.41 USD | -26.74% |
| 2018 | -35.04 USD | -143.0% |
| 2017 | -14.42 USD | -272.61% |
| 2016 | -3.87 USD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | 0.32 USD | 106.4% |
| 2024 Q2 | -1.42 USD | -543.75% |
| 2023 Q3 | -10.25 USD | 6.05% |
| 2023 Q4 | -5.00 USD | 51.22% |
| 2023 Q1 | -9.00 USD | 16.2% |
| 2023 FY | - USD | -2139.49% |
| 2023 Q2 | -10.91 USD | -21.22% |
| 2022 Q1 | 28.94 USD | 373.53% |
| 2022 Q4 | -10.74 USD | -1.61% |
| 2022 Q2 | -9.12 USD | -131.51% |
| 2022 Q3 | -10.57 USD | -15.9% |
| 2022 FY | - USD | 94.96% |
| 2021 Q2 | -9.72 USD | -45533.8% |
| 2021 FY | - USD | 38.21% |
| 2021 Q1 | -0.02 USD | 96.56% |
| 2021 Q4 | -10.58 USD | -9.64% |
| 2021 Q3 | -9.65 USD | 0.72% |
| 2020 Q4 | -0.62 USD | 0.0% |
| 2020 FY | - USD | -13.62% |
| 2020 Q2 | -0.78 USD | 0.0% |
| 2020 Q1 | -0.78 USD | -41.82% |
| 2020 Q3 | -0.62 USD | 20.51% |
| 2019 Q3 | -0.67 USD | -9.84% |
| 2019 Q1 | -0.64 USD | -28.0% |
| 2019 FY | - USD | -26.74% |
| 2019 Q4 | -0.55 USD | 17.91% |
| 2019 Q2 | -0.61 USD | 4.69% |
| 2018 Q2 | -0.34 USD | 91.69% |
| 2018 Q4 | -0.50 USD | -31.58% |
| 2018 FY | - USD | -143.0% |
| 2018 Q1 | -4.09 USD | 10.31% |
| 2018 Q3 | -0.38 USD | -11.76% |
| 2017 Q1 | -2.79 USD | 0.0% |
| 2017 FY | - USD | -272.61% |
| 2017 Q3 | -2.78 USD | -6.51% |
| 2017 Q4 | -4.56 USD | -64.03% |
| 2017 Q2 | -2.61 USD | 6.45% |
| 2016 FY | - USD | 0.0% |